<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104058">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01749800</url>
  </required_header>
  <id_info>
    <org_study_id>2010-P-000010</org_study_id>
    <nct_id>NCT01749800</nct_id>
  </id_info>
  <brief_title>Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits</brief_title>
  <acronym>GVS TBI</acronym>
  <official_title>Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of the proposed project is: (1) to perform a preliminary study to determine
      optimal galvanic vestibular stimulation (GVS) settings based on performance of one cognitive
      test of attention, and (2) to gather preliminary evidence of the effects of GVS in
      combination with computer-based attention training and motor training performed using a
      robotic system designed for rehabilitation, in a small cohort of TBI survivors (20
      subjects).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Jebsen-Taylor Hand Function Test scores from Baseline</measure>
    <time_frame>Baseline, week 4, 2 weeks follow-up (week 6)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Box and Block Test scores from Baseline</measure>
    <time_frame>Baseline, week 4, 2 weeks follow-up (week 6)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>TBI</condition>
  <condition>Attention Deficits</condition>
  <arm_group>
    <arm_group_label>Continous mild GVS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject's stimulation threshold will be determined based on the best performance during attention tests</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham GVS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham galvanic vestibular stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GVS</intervention_name>
    <arm_group_label>Continous mild GVS</arm_group_label>
    <other_name>Device: Model 2200 Analog Stimulus Isolator</other_name>
    <other_name>Produce by: A-M Systems, Inc., WA, USA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham GVS</intervention_name>
    <arm_group_label>Sham GVS</arm_group_label>
    <other_name>Device: Model 2200 Analog Stimulus Isolator</other_name>
    <other_name>Produce by: A-M Systems, Inc., WA, USA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Armeo Spring</intervention_name>
    <arm_group_label>Continous mild GVS</arm_group_label>
    <arm_group_label>Sham GVS</arm_group_label>
    <other_name>Device: Armeo Spring</other_name>
    <other_name>Produced by: Hocoma</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Computer-based attention games</intervention_name>
    <arm_group_label>Continous mild GVS</arm_group_label>
    <arm_group_label>Sham GVS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate to severe traumatic brain injury involving cognitive and/or motor deficits.

          -  Neurological injury &gt;1 year prior to study enrollment

          -  Significant attention deficit

          -  Sufficient voluntary movement and range of motion in their upper extremity to use the
             robotic arm system (ARMEO)

        Exclusion Criteria:

          -  Pregnancy

          -  History of seizures within 6 months of study enrollment

          -  Major depression

          -  Cognitive impairment that may interfere with understanding instructions

          -  Severe limitations of upper extremity range of motion

          -  Agitation

          -  Other major neurological or psychiatric diseases

          -  Participation in other forms of therapy/ intervention for upper extremity motor
             recovery

          -  End-stage liver, kidney, cardiac or pulmonary disease

          -  A terminal medical diagnosis with survival &lt;1 year

          -  History of drug or alcohol abuse in the last 3 years

          -  Adjustment of, or plan to adjust, psychoactive medications within the preceding 1
             month, or within the study period.

          -  Current participation in another interventional trial targeting TBI

          -  Previous GVS treatment

          -  Contraindications to GVS such as implants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Bonato, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spaulding Rehabilitation Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <lastchanged_date>November 20, 2014</lastchanged_date>
  <firstreceived_date>December 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Paolo Bonato</investigator_full_name>
    <investigator_title>Director, Motion Analysis Lab</investigator_title>
  </responsible_party>
  <keyword>TBI</keyword>
  <keyword>Attention deficits</keyword>
  <keyword>upper extremity weakness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
